- |||||||||| Zorbtive (somatropin) / EMD Serono
Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen (clinicaltrials.gov) - Jun 20, 2017 P2, N=19, Completed, Active, not recruiting --> Completed | N=10 --> 19 | Initiation date: Jun 2009 --> Mar 2006 | Trial primary completion date: Apr 2018 --> Jan 2017
- |||||||||| Enrollment change, Surgery: Comparison of Actifuse ABX and Local Bone in Spinal Surgery (clinicaltrials.gov) - Apr 28, 2017
P4, N=14, Terminated, Active, not recruiting --> Completed | N=10 --> 19 | Initiation date: Jun 2009 --> Mar 2006 | Trial primary completion date: Apr 2018 --> Jan 2017 N=60 --> 14
- |||||||||| Trial termination: Correlation Between Sagittal Balance of the Spine and Psychopathological Profile (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=205, Terminated, Enrolling by invitation --> Completed | Trial primary completion date: Nov 2016 --> Aug 2015 Recruiting --> Terminated; Departure of psychologist in charge of questionnaires and scales administered to patients as part of the evaluation of primary endpoint
- |||||||||| Zorbtive (somatropin) / EMD Serono
Enrollment change, Trial initiation date: Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen (clinicaltrials.gov) - Jul 21, 2015 P2, N=9, Active, not recruiting, Recruiting --> Terminated; Departure of psychologist in charge of questionnaires and scales administered to patients as part of the evaluation of primary endpoint N=19 --> 9 | Initiation date: Mar 2006 --> Jun 2009
- |||||||||| Enrollment closed: C-Type Natriuretic Peptide and Achondroplasia (clinicaltrials.gov) - Oct 2, 2014
P=N/A, N=100, Active, not recruiting, Not yet recruiting --> Enrolling by invitation Enrolling by invitation --> Active, not recruiting
|